Effects of tamoxifen and aromatase inhibitors on the risk of acute coronary syndrome in elderly breast cancer patients: An analysis of nationwide data

BACKGROUND: Aromatase inhibitors (AIs) are the preferred endocrine treatment for postmenopausal hormonal receptor-positive breast cancer. However, there is controversy on the long-term cardiovascular and cerebrovascular safety of AIs over that of tamoxifen. METHODS: We analyzed the National Health I...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Sung Hyouk, Kim, Kyoung-Eun, Park, Yujin, Ju, Young Wook, Jung, Ji-Gwang, Lee, Eun Shin, Lee, Han-Byoel, Han, Wonshik, Noh, Dong-Young, Yoon, Hyung-Jin, Moon, Hyeong-Gon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481564/
https://www.ncbi.nlm.nih.gov/pubmed/32890789
http://dx.doi.org/10.1016/j.breast.2020.08.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481564/
https://www.ncbi.nlm.nih.gov/pubmed/32890789
http://dx.doi.org/10.1016/j.breast.2020.08.003

Ejemplares similares